HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CSTONE PHARMA-B

5.785

-0.295-4.85%

Volume:25.00M

Turnover:142.77M

Market Cap:9.23B

PE:-18.38

High:5.990

Open:5.990

Low:5.555

Close:6.080

52wk High:11.190

52wk Low:4.010

Shares:1.60B

HK Float Shares:1.60B

Volume Ratio:1.09

T/O Rate:1.57%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.315

ROE:-52.14%

ROA:-14.44%

PB:6.11

PE(LYR):-18.38

PS:18.57

Loading ...

Overview Company News Filings

Evaluating CStone Pharmaceuticals (SEHK:2616) After ESMO Category I A Backing For Sugemalimab

Simply Wall St.

Stock Track | CSTONE PHARMA-B Soars 6.73% Intraday on Positive CS2009 Trial Data and Analyst Upgrade

CSTONE PHARMA-B Shares Surge Over 6% in Afternoon Trading on Analyst Upgrade

CStone Pharma Reports Marginal Share Capital Movement in March; Issues 3,349 New Shares via Option Exercise

Bulletin Express

CStone Pharmaceuticals shifts to fully electronic distribution of corporate communications effective 2 April 2026

Bulletin Express

Adlai Nortye names Archie Tse president as Kaiyang Tang retires

Gushengtang appoints Boyu Capital partner Cao Yanling as non-executive director

A Look At CStone Pharmaceuticals (SEHK:2616) Valuation After Encouraging CS2009 Trial Results And Wider Losses

Simply Wall St.

Stock Track | CStone Pharma-B Soars 5.04% Intraday on Bullish Analyst Reports and Positive CS2009 Clinical Data

Two Major Foreign Institutions Bullish on CStone Pharma: Peak Target Price Set at HK$20, CS2009 Emerges as Key Catalyst

CStone Pharmaceuticals' Loss Widens in 2025

MT Newswires Live

CStone Pharmaceuticals-B Surges Over 20% by Late Morning on Strong CS2009 Lung Cancer Efficacy Data

CSTONE PHARMA-B (02616) Surges Over 20% on Strong CS2009 Lung Cancer Efficacy Data; First Phase III Global Trials Expected This Year

Stock Track | CStone Pharma Soars 5.51% Intraday on Strong 2025 Results and Promising Pipeline Progress

Press Release: CStone Announces 2025 Annual Results: Accelerated Expansion of Global Commercial Footprint and Efficient Advancement of Innovation Pipeline 2.0

CStone Pharmaceuticals - Loss for the Year Was RMB437.0 Million

THOMSON REUTERS

CStone Pharmaceuticals FY2025; revenue drops 33.8% to RMB 270 million due to lower licensing fees

CStone reports 90% ORR in first-line NSCLC for trispecific antibody CS2009; Phase III global trials slated for 2026

Bulletin Express

CStone Pharmaceuticals-B Unveils Latest Clinical Progress and Phase I/II Key Data for Trispecific Antibody CS2009

CStone Pharmaceuticals reports CS2009 Phase I safety; Grade ≥3 TRAEs rise to 23%

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/02616/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02616","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02616\",,,,,undefined,":{"symbol":"02616","market":"HK","secType":"STK","nameCN":"CSTONE PHARMA-B","latestPrice":5.785,"timestamp":1789114135006,"preClose":6.08,"halted":0,"volume":25003500,"delay":0,"changeRate":-0.04851973684210525,"floatShares":1596000000,"shares":1596000000,"eps":-0.314752,"marketStatus":"Closed","change":-0.295,"latestTime":"09-11 16:08:55","open":5.99,"high":5.99,"low":5.555,"amount":142772085,"amplitude":0.071546,"askPrice":5.79,"askSize":82500,"bidPrice":5.785,"bidSize":7220000,"shortable":3,"etf":0,"ttmEps":-0.302,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":5,"adr":0,"listingDate":1551110400000,"exchange":"SEHK","adjPreClose":6.08,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"volumeRatio":1.089101,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02616\",,,,,undefined,":{"symbol":"02616","floatShares":1596000000,"roa":"-14.44%","roe":"-52.14%","lyrEps":-0.314752,"volumeRatio":1.089101,"shares":1596000000,"dividePrice":0,"high":5.99,"amplitude":0.071546,"preClose":6.08,"low":5.555,"week52Low":4.01,"pbRate":"6.11","psRate":"18.57","week52High":11.19,"institutionHeld":0,"latestPrice":5.785,"committee":0.977405,"eps":-0.314752,"divideRate":0,"volume":25003500,"delay":0,"ttmEps":-0.302,"open":5.99,"prevYearClose":5.27,"prevWeekClose":6.19,"prevMonthClose":5.75,"prevQuarterClose":4.71,"fiveDayClose":6.19,"twentyDayClose":5.745,"sixtyDayClose":4.56},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02616\",params:#limit:5,,,undefined,":[{"date":"2026-08-27","symbol":"02616","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787794200000,"name":null,"time":"","dateTimestamp":1787760000000,"actualEps":null},{"date":"2026-03-26","symbol":"02616","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774488600000,"name":null,"time":"","dateTimestamp":1774454400000,"actualEps":null},{"date":"2025-08-14","symbol":"02616","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755135000000,"name":null,"time":"","dateTimestamp":1755100800000,"actualEps":null},{"date":"2025-03-27","symbol":"02616","type":"earning","reportTimeType":"pre","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743039000000,"name":null,"time":"Pre-MKt","dateTimestamp":1743004800000,"actualEps":null},{"date":"2024-08-23","symbol":"02616","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724376600000,"name":null,"time":"","dateTimestamp":1724342400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02616\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02616\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1775145600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02616\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02616","date":"2026-09-10","current":-19.155629,"percent":0.255528,"low":-136.537801,"twenty":-21.889079,"median":-4.358449,"eighty":-2.920396,"high":-1.28563,"avg":-13.995628,"sd":18.346844,"marketCap":9692202960},"quantilePoints":[{"date":"2021-09-17","current":-8.949727,"twenty":-11.20047,"median":-8.434657,"eighty":-5.3787,"marketCap":14255979177},{"date":"2021-09-24","current":-8.234007,"twenty":-11.19935,"median":-8.434657,"eighty":-5.380222,"marketCap":13121980833},{"date":"2021-09-30","current":-7.839337,"twenty":-11.192661,"median":-8.399615,"eighty":-5.382695,"marketCap":12534829867},{"date":"2021-10-08","current":-7.345169,"twenty":-11.111271,"median":-8.201573,"eighty":-5.38891,"marketCap":11744135590},{"date":"2021-10-15","current":-7.158447,"twenty":-11.047167,"median":-8.13024,"eighty":-5.402482,"marketCap":11453439164},{"date":"2021-10-22","current":-7.107419,"twenty":-11.021608,"median":-8.052957,"eighty":-5.419451,"marketCap":11453439164},{"date":"2021-10-29","current":-6.9876,"twenty":-10.913219,"median":-7.905378,"eighty":-5.424788,"marketCap":11232509881},{"date":"2021-11-05","current":-6.521477,"twenty":-10.751223,"median":-7.736229,"eighty":-5.429889,"marketCap":10500496508},{"date":"2021-11-12","current":-6.911857,"twenty":-10.72568,"median":-7.556243,"eighty":-5.439163,"marketCap":11174947004},{"date":"2021-11-19","current":-7.562679,"twenty":-10.701803,"median":-7.433682,"eighty":-5.461865,"marketCap":12209879661},{"date":"2021-11-26","current":-7.617861,"twenty":-10.663803,"median":-7.561565,"eighty":-5.484543,"marketCap":12302907315},{"date":"2021-12-03","current":-7.259305,"twenty":-10.643156,"median":-7.468211,"eighty":-5.498458,"marketCap":11745511604},{"date":"2021-12-10","current":-6.694442,"twenty":-10.638167,"median":-7.415818,"eighty":-5.502206,"marketCap":10850061709},{"date":"2021-12-17","current":-6.016959,"twenty":-10.577662,"median":-7.345169,"eighty":-5.508139,"marketCap":9745285865},{"date":"2021-12-24","current":-6.061431,"twenty":-10.471572,"median":-7.288494,"eighty":-5.512987,"marketCap":9826690401},{"date":"2021-12-31","current":-5.927226,"twenty":-10.433659,"median":-7.259398,"eighty":-5.512973,"marketCap":9630021066},{"date":"2022-01-07","current":-5.24476,"twenty":-5.885319,"median":-5.561747,"eighty":-5.274171,"marketCap":8488857748},{"date":"2022-01-14","current":-5.434369,"twenty":-5.739435,"median":-5.400163,"eighty":-5.320351,"marketCap":8814904410},{"date":"2022-01-21","current":-5.350332,"twenty":-5.667482,"median":-5.495343,"eighty":-5.345425,"marketCap":8698459174},{"date":"2022-01-28","current":-4.179198,"twenty":-5.655726,"median":-5.359716,"eighty":-5.156862,"marketCap":6777112770},{"date":"2022-02-04","current":-4.314568,"twenty":-5.65234,"median":-5.352863,"eighty":-4.82542,"marketCap":6993202476},{"date":"2022-02-11","current":-4.305871,"twenty":-5.588386,"median":-5.338065,"eighty":-4.357596,"marketCap":6993202476},{"date":"2022-02-18","current":-4.549058,"twenty":-5.561747,"median":-5.217261,"eighty":-4.357596,"marketCap":7424449962},{"date":"2022-02-25","current":-4.580613,"twenty":-5.541925,"median":-4.82542,"eighty":-4.340347,"marketCap":7494381986},{"date":"2022-03-04","current":-4.265532,"twenty":-5.495343,"median":-4.615232,"eighty":-4.340347,"marketCap":6981547138},{"date":"2022-03-11","current":-3.829807,"twenty":-5.434369,"median":-4.592981,"eighty":-4.305871,"marketCap":6258916216},{"date":"2022-03-18","current":-3.70909,"twenty":-5.365958,"median":-4.554202,"eighty":-4.254145,"marketCap":6037464804},{"date":"2022-03-25","current":-4.009659,"twenty":-5.353473,"median":-4.514341,"eighty":-4.051774,"marketCap":6526988977},{"date":"2022-04-01","current":-3.604513,"twenty":-5.352254,"median":-4.446056,"eighty":-3.939197,"marketCap":5874464342},{"date":"2022-04-08","current":-3.602952,"twenty":-5.350716,"median":-4.358449,"eighty":-3.856607,"marketCap":5874464342},{"date":"2022-04-14","current":-3.608921,"twenty":-5.342972,"median":-4.33861,"eighty":-3.719598,"marketCap":5874464342},{"date":"2022-04-22","current":-3.677661,"twenty":-5.320351,"median":-4.323136,"eighty":-3.639031,"marketCap":5874464342},{"date":"2022-04-29","current":-3.73782,"twenty":-5.274171,"median":-4.305768,"eighty":-3.660706,"marketCap":5874464342},{"date":"2022-05-06","current":-3.769129,"twenty":-5.23376,"median":-4.265532,"eighty":-3.683855,"marketCap":5874464342},{"date":"2022-05-13","current":-3.837797,"twenty":-5.189762,"median":-4.179198,"eighty":-3.708631,"marketCap":5874464342},{"date":"2022-05-20","current":-3.784694,"twenty":-5.107513,"median":-4.086461,"eighty":-3.70909,"marketCap":5874464342},{"date":"2022-05-27","current":-3.78798,"twenty":-4.82542,"median":-4.009659,"eighty":-3.709727,"marketCap":5874464342},{"date":"2022-06-02","current":-3.812613,"twenty":-4.725127,"median":-3.992083,"eighty":-3.710569,"marketCap":5944398442},{"date":"2022-06-10","current":-2.879454,"twenty":-4.638595,"median":-3.924041,"eighty":-3.708998,"marketCap":6468904187},{"date":"2022-06-17","current":-2.534624,"twenty":-4.610433,"median":-3.837797,"eighty":-3.629407,"marketCap":5687973411},{"date":"2022-06-24","current":-2.91257,"twenty":-4.600342,"median":-3.834186,"eighty":-3.605183,"marketCap":6562149652},{"date":"2022-06-30","current":-2.7397,"twenty":-4.595236,"median":-3.824248,"eighty":-3.603889,"marketCap":6162036300},{"date":"2022-07-08","current":-2.789013,"twenty":-4.58556,"median":-3.810066,"eighty":-3.585543,"marketCap":6279408420},{"date":"2022-07-15","current":-2.657247,"twenty":-4.567853,"median":-3.804578,"eighty":-3.040197,"marketCap":5927292060},{"date":"2022-07-22","current":-2.439909,"twenty":-4.553174,"median":-3.796104,"eighty":-2.88352,"marketCap":5446066368},{"date":"2022-07-29","current":-2.179587,"twenty":-4.54278,"median":-3.786337,"eighty":-2.825625,"marketCap":4870942980},{"date":"2022-08-05","current":-2.179915,"twenty":-4.524043,"median":-3.773711,"eighty":-2.777759,"marketCap":4859266866},{"date":"2022-08-12","current":-2.113849,"twenty":-4.48743,"median":-3.764949,"eighty":-2.726876,"marketCap":4718418551},{"date":"2022-08-19","current":-2.12991,"twenty":-4.458004,"median":-3.759652,"eighty":-2.661134,"marketCap":4706681191},{"date":"2022-08-26","current":-2.634132,"twenty":-4.445198,"median":-3.737568,"eighty":-2.601682,"marketCap":5774780913},{"date":"2022-09-02","current":-2.482455,"twenty":-4.392287,"median":-3.726604,"eighty":-2.570557,"marketCap":5422721701},{"date":"2022-09-09","current":-2.357096,"twenty":-4.358278,"median":-3.709409,"eighty":-2.530744,"marketCap":5129284379},{"date":"2022-09-16","current":-2.422633,"twenty":-4.350696,"median":-3.693146,"eighty":-2.492961,"marketCap":5223184322},{"date":"2022-09-23","current":-2.643578,"twenty":-4.338957,"median":-3.632117,"eighty":-2.424059,"marketCap":4389822329},{"date":"2022-09-30","current":-2.491968,"twenty":-4.334804,"median":-3.607643,"eighty":-2.431682,"marketCap":4145970216},{"date":"2022-10-07","current":-2.435149,"twenty":-4.328276,"median":-3.604942,"eighty":-2.427988,"marketCap":4051205182},{"date":"2022-10-14","current":-2.569205,"twenty":-4.312829,"median":-3.604513,"eighty":-2.427988,"marketCap":4228889620},{"date":"2022-10-21","current":-2.789816,"twenty":-4.30585,"median":-3.6011,"eighty":-2.436101,"marketCap":4560567238},{"date":"2022-10-28","current":-2.620394,"twenty":-4.30145,"median":-3.574811,"eighty":-2.447476,"marketCap":4276272137},{"date":"2022-11-04","current":-2.801766,"twenty":-4.280449,"median":-3.186067,"eighty":-2.475622,"marketCap":4616748608},{"date":"2022-11-11","current":-2.534296,"twenty":-4.263255,"median":-2.894354,"eighty":-2.478687,"marketCap":4213228164},{"date":"2022-11-18","current":-2.700603,"twenty":-4.239156,"median":-2.889868,"eighty":-2.483082,"marketCap":4474329627},{"date":"2022-11-25","current":-2.418931,"twenty":-4.177717,"median":-2.865074,"eighty":-2.475622,"marketCap":3975863197},{"date":"2022-12-02","current":-2.643918,"twenty":-4.161664,"median":-2.86319,"eighty":-2.462906,"marketCap":4420662516},{"date":"2022-12-09","current":-3.149151,"twenty":-4.107273,"median":-2.864198,"eighty":-2.475622,"marketCap":5314327445},{"date":"2022-12-16","current":-3.305139,"twenty":-4.051044,"median":-2.882842,"eighty":-2.478576,"marketCap":5564553626},{"date":"2022-12-23","current":-3.381937,"twenty":-4.04043,"median":-2.894354,"eighty":-2.482013,"marketCap":5695624482},{"date":"2022-12-30","current":-3.236489,"twenty":-4.017352,"median":-2.91136,"eighty":-2.482344,"marketCap":5516891496},{"date":"2023-01-06","current":-3.391948,"twenty":-4.007837,"median":-2.931792,"eighty":-2.484335,"marketCap":5841286276},{"date":"2023-01-13","current":-3.599992,"twenty":-3.997899,"median":-3.028307,"eighty":-2.489094,"marketCap":6318125972},{"date":"2023-01-20","current":-3.274887,"twenty":-3.960351,"median":-3.067138,"eighty":-2.491753,"marketCap":5698234367},{"date":"2023-01-27","current":-3.233118,"twenty":-3.939197,"median":-3.097872,"eighty":-2.491968,"marketCap":5626708412},{"date":"2023-02-03","current":-3.69441,"twenty":-3.928643,"median":-3.149151,"eighty":-2.494486,"marketCap":6462803880},{"date":"2023-02-10","current":-2.982995,"twenty":-3.919438,"median":-3.165799,"eighty":-2.508719,"marketCap":5186936694},{"date":"2023-02-17","current":-2.929036,"twenty":-3.863307,"median":-3.125282,"eighty":-2.512289,"marketCap":5044936998},{"date":"2023-02-24","current":-2.815147,"twenty":-3.837797,"median":-3.067138,"eighty":-2.524925,"marketCap":4789497150},{"date":"2023-03-03","current":-3.177519,"twenty":-3.836172,"median":-3.062189,"eighty":-2.525861,"marketCap":5440868762},{"date":"2023-03-10","current":-2.780338,"twenty":-2.887457,"median":-2.862997,"eighty":-2.813402,"marketCap":4725637188},{"date":"2023-03-17","current":-2.887659,"twenty":-6.745058,"median":-4.593114,"eighty":-3.296279,"marketCap":4955533051},{"date":"2023-03-24","current":-2.612069,"twenty":-6.736768,"median":-4.588347,"eighty":-3.266896,"marketCap":4534057302},{"date":"2023-03-31","current":-2.632175,"twenty":-6.734568,"median":-4.584133,"eighty":-3.247746,"marketCap":4534057302},{"date":"2023-04-06","current":-2.745164,"twenty":-6.732299,"median":-4.58201,"eighty":-3.245554,"marketCap":4725637188},{"date":"2023-04-14","current":-2.905521,"twenty":-6.72346,"median":-4.55657,"eighty":-3.235845,"marketCap":5006621020},{"date":"2023-04-21","current":-2.588135,"twenty":-6.708866,"median":-4.546798,"eighty":-3.196989,"marketCap":4457425347},{"date":"2023-04-28","current":-4.143444,"twenty":-6.693682,"median":-4.538595,"eighty":-3.180289,"marketCap":4240301476},{"date":"2023-05-05","current":-3.999602,"twenty":-6.69064,"median":-4.52917,"eighty":-3.191368,"marketCap":4099809560},{"date":"2023-05-12","current":-3.806764,"twenty":-6.679014,"median":-4.522481,"eighty":-3.196275,"marketCap":3875269876},{"date":"2023-05-19","current":-3.771563,"twenty":-6.673396,"median":-4.514341,"eighty":-3.199843,"marketCap":3785445740},{"date":"2023-05-25","current":-3.684445,"twenty":-6.661445,"median":-4.512446,"eighty":-3.226463,"marketCap":3682789585},{"date":"2023-06-02","current":-3.632573,"twenty":-6.658053,"median":-4.486619,"eighty":-3.234956,"marketCap":3618629487},{"date":"2023-06-09","current":-3.392773,"twenty":-6.652326,"median":-4.462291,"eighty":-3.236274,"marketCap":3374873717},{"date":"2023-06-16","current":-3.564649,"twenty":-6.635685,"median":-4.45465,"eighty":-3.234956,"marketCap":3528860351},{"date":"2023-06-23","current":-3.010726,"twenty":-6.610775,"median":-4.450713,"eighty":-3.234497,"marketCap":2964242695},{"date":"2023-06-30","current":-3.274952,"twenty":-6.583541,"median":-4.44228,"eighty":-3.234497,"marketCap":3195222645},{"date":"2023-07-07","current":-3.189107,"twenty":-6.573211,"median":-4.4415,"eighty":-3.21706,"marketCap":3105397109},{"date":"2023-07-14","current":-3.365903,"twenty":-6.569768,"median":-4.430064,"eighty":-3.234037,"marketCap":3323544840},{"date":"2023-07-21","current":-3.120491,"twenty":-6.567361,"median":-4.417451,"eighty":-3.210165,"marketCap":3066900450},{"date":"2023-07-28","current":-3.346032,"twenty":-6.564413,"median":-4.408129,"eighty":-3.196989,"marketCap":3285048181},{"date":"2023-08-04","current":-3.027308,"twenty":-6.564342,"median":-4.399316,"eighty":-3.194165,"marketCap":2977074914},{"date":"2023-08-11","current":-2.782359,"twenty":-6.564014,"median":-4.396571,"eighty":-3.189107,"marketCap":2720740259},{"date":"2023-08-18","current":-3.530437,"twenty":-6.55969,"median":-4.392518,"eighty":-3.172846,"marketCap":2849077064},{"date":"2023-08-25","current":-3.655856,"twenty":-6.554405,"median":-4.381873,"eighty":-3.176536,"marketCap":2951746508},{"date":"2023-09-01","current":-3.530032,"twenty":-6.533968,"median":-4.371418,"eighty":-3.184472,"marketCap":2861990034},{"date":"2023-09-08","current":-3.411902,"twenty":-6.518159,"median":-4.359552,"eighty":-3.189107,"marketCap":2733649674},{"date":"2023-09-15","current":-3.09954,"twenty":-6.509248,"median":-4.356975,"eighty":-3.184472,"marketCap":2502637025},{"date":"2023-09-22","current":-3.081221,"twenty":-6.493183,"median":-4.345154,"eighty":-3.172846,"marketCap":2476968953},{"date":"2023-09-29","current":-2.926752,"twenty":-6.480354,"median":-4.336586,"eighty":-3.159724,"marketCap":2356828062},{"date":"2023-10-06","current":-2.754135,"twenty":-6.470259,"median":-4.332194,"eighty":-3.149993,"marketCap":2216761940},{"date":"2023-10-13","current":-3.075296,"twenty":-6.459774,"median":-4.326035,"eighty":-3.128987,"marketCap":2471562163},{"date":"2023-10-20","current":-2.889523,"twenty":-6.458144,"median":-4.318868,"eighty":-3.124306,"marketCap":2318682029},{"date":"2023-10-27","current":-3.129013,"twenty":-6.456543,"median":-4.317435,"eighty":-3.120688,"marketCap":2509782196},{"date":"2023-11-03","current":-3.405912,"twenty":-6.449456,"median":-4.315677,"eighty":-3.121913,"marketCap":2739136797},{"date":"2023-11-10","current":-3.707675,"twenty":-6.422586,"median":-4.311136,"eighty":-3.12398,"marketCap":2981200049},{"date":"2023-11-17","current":-3.643128,"twenty":-6.418119,"median":-4.306778,"eighty":-3.125305,"marketCap":2955719706},{"date":"2023-11-24","current":-3.862579,"twenty":-6.411963,"median":-4.304547,"eighty":-3.125437,"marketCap":3159562445},{"date":"2023-12-01","current":-3.443396,"twenty":-6.402415,"median":-4.299316,"eighty":-3.125763,"marketCap":2828353515},{"date":"2023-12-08","current":-3.70655,"twenty":-6.380708,"median":-4.294096,"eighty":-3.126978,"marketCap":3032198813},{"date":"2023-12-15","current":-3.933018,"twenty":-6.355629,"median":-4.286687,"eighty":-3.129763,"marketCap":3236044112},{"date":"2023-12-22","current":-3.362344,"twenty":-6.341861,"median":-4.283518,"eighty":-3.135873,"marketCap":2764651859},{"date":"2023-12-29","current":-3.498637,"twenty":-6.326391,"median":-4.279732,"eighty":-3.145199,"marketCap":2892055171},{"date":"2024-01-05","current":-3.352806,"twenty":-6.311476,"median":-4.275394,"eighty":-3.148813,"marketCap":2751961912},{"date":"2024-01-12","current":-3.319994,"twenty":-6.301095,"median":-4.271829,"eighty":-3.150414,"marketCap":2726480783},{"date":"2024-01-19","current":-2.920642,"twenty":-6.289048,"median":-4.265098,"eighty":-3.14209,"marketCap":2395226109},{"date":"2024-01-26","current":-2.776093,"twenty":-6.275971,"median":-4.258402,"eighty":-3.125512,"marketCap":2267820464},{"date":"2024-02-02","current":-2.436086,"twenty":-6.260618,"median":-4.252597,"eighty":-3.121083,"marketCap":1987528047},{"date":"2024-02-09","current":-2.501845,"twenty":-6.25276,"median":-4.24782,"eighty":-3.105335,"marketCap":2051230870},{"date":"2024-02-16","current":-2.392552,"twenty":-6.251579,"median":-4.245111,"eighty":-3.084885,"marketCap":1962046919},{"date":"2024-02-23","current":-2.51456,"twenty":-6.247289,"median":-4.239252,"eighty":-3.064189,"marketCap":2051230870},{"date":"2024-03-01","current":-2.310081,"twenty":-6.222174,"median":-4.222385,"eighty":-3.040692,"marketCap":1885603532},{"date":"2024-03-08","current":-1.404154,"twenty":-6.191591,"median":-4.219168,"eighty":-3.008293,"marketCap":1146650796},{"date":"2024-03-15","current":-1.639631,"twenty":-6.153575,"median":-4.207661,"eighty":-2.990736,"marketCap":1337759263},{"date":"2024-03-22","current":-1.469204,"twenty":-6.137344,"median":-4.193365,"eighty":-2.948454,"marketCap":1197613054},{"date":"2024-03-28","current":-1.473918,"twenty":-6.118661,"median":-4.179198,"eighty":-2.936832,"marketCap":1197613054},{"date":"2024-04-05","current":-1.380747,"twenty":-6.07926,"median":-4.170971,"eighty":-2.929036,"marketCap":1121169668},{"date":"2024-04-12","current":-1.34863,"twenty":-6.060479,"median":-4.143701,"eighty":-2.916836,"marketCap":1095711942},{"date":"2024-04-19","current":-1.334087,"twenty":-6.029373,"median":-4.129341,"eighty":-2.905689,"marketCap":1082971105},{"date":"2024-04-26","current":-2.889721,"twenty":-6.019873,"median":-4.121148,"eighty":-2.897368,"marketCap":1146675288},{"date":"2024-05-03","current":-3.534325,"twenty":-5.992843,"median":-4.105499,"eighty":-2.894248,"marketCap":1401492019},{"date":"2024-05-10","current":-3.465269,"twenty":-5.966361,"median":-4.068484,"eighty":-2.894248,"marketCap":1377371440},{"date":"2024-05-17","current":-4.209422,"twenty":-5.951813,"median":-4.055358,"eighty":-2.894248,"marketCap":1670700543},{"date":"2024-05-24","current":-4.186851,"twenty":-5.939876,"median":-4.055358,"eighty":-2.894248,"marketCap":1657947103},{"date":"2024-05-31","current":-3.732161,"twenty":-5.929989,"median":-4.038887,"eighty":-2.894248,"marketCap":1479398954},{"date":"2024-06-07","current":-3.76901,"twenty":-5.876484,"median":-4.028312,"eighty":-2.894248,"marketCap":1492152393},{"date":"2024-06-14","current":-3.482276,"twenty":-5.858022,"median":-3.999602,"eighty":-2.894248,"marketCap":1377371440},{"date":"2024-06-21","current":-3.521893,"twenty":-5.826591,"median":-3.984491,"eighty":-2.894248,"marketCap":1390124879},{"date":"2024-06-28","current":-3.684975,"twenty":-5.785726,"median":-3.960681,"eighty":-2.894248,"marketCap":1453892075},{"date":"2024-07-05","current":-3.976759,"twenty":-5.708926,"median":-3.94724,"eighty":-2.894248,"marketCap":1568673028},{"date":"2024-07-12","current":-3.809506,"twenty":-5.666111,"median":-3.939197,"eighty":-2.894248,"marketCap":1504905832},{"date":"2024-07-19","current":-3.938567,"twenty":-5.64627,"median":-3.936259,"eighty":-2.894248,"marketCap":1555919589},{"date":"2024-07-26","current":-3.859662,"twenty":-5.597338,"median":-3.926532,"eighty":-2.894248,"marketCap":1530412711},{"date":"2024-08-02","current":-4.119373,"twenty":-5.565391,"median":-3.926532,"eighty":-2.894248,"marketCap":1632440225},{"date":"2024-08-09","current":-3.996192,"twenty":-5.542318,"median":-3.926532,"eighty":-2.894248,"marketCap":1594179907},{"date":"2024-08-16","current":-4.218339,"twenty":-5.531989,"median":-3.926532,"eighty":-2.894248,"marketCap":1683453982},{"date":"2024-08-23","current":-4.073295,"twenty":-5.531989,"median":-3.926532,"eighty":-2.894248,"marketCap":1632440225},{"date":"2024-08-30","current":-4.899612,"twenty":-5.531989,"median":-3.926532,"eighty":-2.894248,"marketCap":1976783085},{"date":"2024-09-06","current":-4.739277,"twenty":-5.531989,"median":-3.926532,"eighty":-2.894248,"marketCap":1913015889},{"date":"2024-09-13","current":-4.720038,"twenty":-5.531989,"median":-3.926532,"eighty":-2.894248,"marketCap":1900262449},{"date":"2024-09-20","current":-4.628923,"twenty":-5.53413,"median":-3.925687,"eighty":-2.894194,"marketCap":1874755571},{"date":"2024-09-27","current":-5.446446,"twenty":-5.53413,"median":-3.925687,"eighty":-2.894194,"marketCap":2219126271},{"date":"2024-10-04","current":-15.755499,"twenty":-5.548662,"median":-3.925687,"eighty":-2.894194,"marketCap":2476357202},{"date":"2024-10-10","current":-14.135917,"twenty":-5.573446,"median":-3.926532,"eighty":-2.894248,"marketCap":2208297918},{"date":"2024-10-18","current":-14.462213,"twenty":-5.610768,"median":-3.925687,"eighty":-2.894194,"marketCap":2246592101},{"date":"2024-10-25","current":-17.175371,"twenty":-5.653982,"median":-3.925687,"eighty":-2.894194,"marketCap":2667890820},{"date":"2024-11-01","current":-17.245924,"twenty":-5.680834,"median":-3.925687,"eighty":-2.894194,"marketCap":2680655848},{"date":"2024-11-08","current":-16.219086,"twenty":-5.78614,"median":-3.925687,"eighty":-2.894194,"marketCap":2501945458},{"date":"2024-11-15","current":-15.508794,"twenty":-5.827373,"median":-3.925687,"eighty":-2.894194,"marketCap":2374295180},{"date":"2024-11-22","current":-16.352011,"twenty":-5.9148,"median":-3.925687,"eighty":-2.894194,"marketCap":2501945458},{"date":"2024-11-29","current":-17.863888,"twenty":-5.953064,"median":-3.925687,"eighty":-2.894194,"marketCap":2731715959},{"date":"2024-12-06","current":-18.910143,"twenty":-5.976081,"median":-3.925687,"eighty":-2.894194,"marketCap":2884896294},{"date":"2024-12-13","current":-22.026126,"twenty":-6.008757,"median":-3.925687,"eighty":-2.894194,"marketCap":3357202324},{"date":"2024-12-20","current":-19.368719,"twenty":-6.038268,"median":-3.925687,"eighty":-2.894194,"marketCap":2935956405},{"date":"2024-12-27","current":-19.29948,"twenty":-6.089632,"median":-3.925687,"eighty":-2.894194,"marketCap":2923191377},{"date":"2025-01-03","current":-20.796109,"twenty":-6.174931,"median":-3.925687,"eighty":-2.894194,"marketCap":3152961878},{"date":"2025-01-10","current":-18.25524,"twenty":-6.25082,"median":-3.925687,"eighty":-2.894194,"marketCap":2757246015},{"date":"2025-01-17","current":-18.24052,"twenty":-6.445489,"median":-3.927588,"eighty":-2.894194,"marketCap":2757246015},{"date":"2025-01-24","current":-20.141042,"twenty":-6.555254,"median":-3.927588,"eighty":-2.894194,"marketCap":3063606684},{"date":"2025-01-28","current":-19.53514,"twenty":-6.564014,"median":-3.928643,"eighty":-2.894248,"marketCap":2987016516},{"date":"2025-02-07","current":-19.814213,"twenty":-6.620453,"median":-3.926532,"eighty":-2.894141,"marketCap":3012546572},{"date":"2025-02-14","current":-22.723068,"twenty":-6.67789,"median":-3.926532,"eighty":-2.894141,"marketCap":3446557519},{"date":"2025-02-21","current":-26.033767,"twenty":-6.7434,"median":-3.926532,"eighty":-2.894141,"marketCap":3970369498},{"date":"2025-02-28","current":-28.807424,"twenty":-6.911713,"median":-3.926532,"eighty":-2.894141,"marketCap":4378896263},{"date":"2025-03-07","current":-28.524923,"twenty":-6.9876,"median":-3.922985,"eighty":-2.894088,"marketCap":4353363340},{"date":"2025-03-14","current":-30.855919,"twenty":-7.094956,"median":-3.927588,"eighty":-2.894088,"marketCap":4710824260},{"date":"2025-03-21","current":-29.696894,"twenty":-7.19083,"median":-3.938173,"eighty":-2.894088,"marketCap":4532093800},{"date":"2025-03-28","current":-44.206211,"twenty":-7.281486,"median":-3.953184,"eighty":-2.894088,"marketCap":4315063956},{"date":"2025-04-03","current":-40.26858,"twenty":-7.377266,"median":-3.972131,"eighty":-2.894088,"marketCap":3932070114},{"date":"2025-04-11","current":-31.529554,"twenty":-7.521044,"median":-3.977907,"eighty":-2.894088,"marketCap":3051184276},{"date":"2025-04-17","current":-35.141039,"twenty":-7.612577,"median":-3.984806,"eighty":-2.894141,"marketCap":3405181813},{"date":"2025-04-25","current":-39.824039,"twenty":-7.830066,"median":-3.999602,"eighty":-2.893971,"marketCap":3866441501},{"date":"2025-05-02","current":-40.436758,"twenty":-7.971418,"median":-4.00659,"eighty":-2.894088,"marketCap":3934273808},{"date":"2025-05-09","current":-37.951173,"twenty":-8.125706,"median":-4.030136,"eighty":-2.904367,"marketCap":3718361371},{"date":"2025-05-16","current":-39.292255,"twenty":-8.402557,"median":-4.054969,"eighty":-2.909393,"marketCap":3881209314},{"date":"2025-05-23","current":-48.489427,"twenty":-8.76248,"median":-4.07123,"eighty":-2.912068,"marketCap":4804014326},{"date":"2025-05-30","current":-54.004979,"twenty":-8.882707,"median":-4.108578,"eighty":-2.920581,"marketCap":5373982128},{"date":"2025-06-06","current":-53.187404,"twenty":-9.067711,"median":-4.134025,"eighty":-2.920581,"marketCap":5306128818},{"date":"2025-06-13","current":-62.277497,"twenty":-9.366509,"median":-4.171793,"eighty":-2.920581,"marketCap":6215439503},{"date":"2025-06-20","current":-55.860088,"twenty":-9.719391,"median":-4.1939,"eighty":-2.920581,"marketCap":5564039730},{"date":"2025-06-27","current":-57.470323,"twenty":-9.919518,"median":-4.210698,"eighty":-2.920642,"marketCap":5740460502},{"date":"2025-07-04","current":-70.509918,"twenty":-9.96315,"median":-4.214054,"eighty":-2.920642,"marketCap":7043260048},{"date":"2025-07-11","current":-72.89851,"twenty":-10.187483,"median":-4.217237,"eighty":-2.920642,"marketCap":7274522110},{"date":"2025-07-18","current":-96.028249,"twenty":-10.444237,"median":-4.259839,"eighty":-2.920642,"marketCap":9575122927},{"date":"2025-07-25","current":-109.369715,"twenty":-10.675922,"median":-4.302518,"eighty":-2.920642,"marketCap":10945079632},{"date":"2025-08-01","current":-98.766317,"twenty":-11.028128,"median":-4.334288,"eighty":-2.920642,"marketCap":9822881055},{"date":"2025-08-08","current":-102.320343,"twenty":-11.210508,"median":-4.343155,"eighty":-2.920642,"marketCap":10201805250},{"date":"2025-08-15","current":-136.537801,"twenty":-11.629311,"median":-4.351854,"eighty":-2.920642,"marketCap":13593043587},{"date":"2025-08-22","current":-34.413615,"twenty":-11.870503,"median":-4.358449,"eighty":-2.920642,"marketCap":14120359933},{"date":"2025-08-29","current":-38.22937,"twenty":-12.785549,"median":-4.358449,"eighty":-2.920642,"marketCap":15760899677},{"date":"2025-09-05","current":-43.631932,"twenty":-13.262082,"median":-4.358449,"eighty":-2.920642,"marketCap":17970398621},{"date":"2025-09-12","current":-35.323219,"twenty":-13.467457,"median":-4.378646,"eighty":-2.920642,"marketCap":14574532540},{"date":"2025-09-19","current":-30.095318,"twenty":-13.678999,"median":-4.405143,"eighty":-2.920642,"marketCap":12408662899},{"date":"2025-09-26","current":-26.446279,"twenty":-14.059898,"median":-4.4171,"eighty":-2.920642,"marketCap":10875828070},{"date":"2025-10-03","current":-28.012348,"twenty":-14.148515,"median":-4.421903,"eighty":-2.921048,"marketCap":11547355709},{"date":"2025-10-10","current":-24.116553,"twenty":-14.462213,"median":-4.4171,"eighty":-2.920642,"marketCap":9926930319},{"date":"2025-10-17","current":-24.725072,"twenty":-15.180426,"median":-4.4171,"eighty":-2.920642,"marketCap":10169487889},{"date":"2025-10-24","current":-22.615857,"twenty":-15.755499,"median":-4.4171,"eighty":-2.920642,"marketCap":9305344739},{"date":"2025-10-31","current":-22.367787,"twenty":-16.219086,"median":-4.4171,"eighty":-2.920642,"marketCap":9217002859},{"date":"2025-11-07","current":-19.414218,"twenty":-16.550087,"median":-4.4171,"eighty":-2.920642,"marketCap":7994940179},{"date":"2025-11-14","current":-21.676779,"twenty":-16.716727,"median":-4.4171,"eighty":-2.920642,"marketCap":8951977217},{"date":"2025-11-21","current":-19.867752,"twenty":-17.175371,"median":-4.4171,"eighty":-2.920642,"marketCap":8201071234},{"date":"2025-11-28","current":-21.715013,"twenty":-17.817357,"median":-4.4171,"eighty":-2.920642,"marketCap":8996148158},{"date":"2025-12-05","current":-20.116662,"twenty":-18.156074,"median":-4.4171,"eighty":-2.920642,"marketCap":8348307701},{"date":"2025-12-12","current":-21.673135,"twenty":-18.597879,"median":-4.4171,"eighty":-2.920642,"marketCap":9010871804},{"date":"2025-12-19","current":-21.268873,"twenty":-18.932983,"median":-4.4171,"eighty":-2.920642,"marketCap":8863635337},{"date":"2025-12-24","current":-19.934886,"twenty":-19.027132,"median":-4.4171,"eighty":-2.920642,"marketCap":8333584054},{"date":"2026-01-02","current":-18.734094,"twenty":-19.229249,"median":-4.412297,"eighty":-2.920581,"marketCap":7862427359},{"date":"2026-01-09","current":-20.262357,"twenty":-19.347505,"median":-4.412297,"eighty":-2.920581,"marketCap":8524991462},{"date":"2026-01-16","current":-21.312952,"twenty":-19.438402,"median":-4.412297,"eighty":-2.920581,"marketCap":8996148158},{"date":"2026-01-23","current":-19.727354,"twenty":-19.550014,"median":-4.412297,"eighty":-2.920581,"marketCap":8318882544},{"date":"2026-01-30","current":-18.664391,"twenty":-19.550014,"median":-4.412297,"eighty":-2.920581,"marketCap":7906619339},{"date":"2026-02-06","current":-17.611774,"twenty":-19.550014,"median":-4.412297,"eighty":-2.920581,"marketCap":7479632447},{"date":"2026-02-13","current":-20.40709,"twenty":-19.573276,"median":-4.4171,"eighty":-2.920642,"marketCap":8716570064},{"date":"2026-02-20","current":-21.334077,"twenty":-19.730666,"median":-4.385799,"eighty":-2.920519,"marketCap":9099392398},{"date":"2026-02-27","current":-22.809976,"twenty":-19.827105,"median":-4.385799,"eighty":-2.920519,"marketCap":9835589194},{"date":"2026-03-06","current":-22.892085,"twenty":-19.876517,"median":-4.385799,"eighty":-2.920519,"marketCap":9791417386},{"date":"2026-03-13","current":-24.363526,"twenty":-19.939651,"median":-4.385799,"eighty":-2.920519,"marketCap":10468779101},{"date":"2026-03-20","current":-23.561814,"twenty":-20.090468,"median":-4.385799,"eighty":-2.920519,"marketCap":10085954549},{"date":"2026-03-27","current":-24.787283,"twenty":-20.254301,"median":-4.385799,"eighty":-2.920519,"marketCap":12265109692},{"date":"2026-04-02","current":-27.689391,"twenty":-20.348654,"median":-4.385799,"eighty":-2.920519,"marketCap":13766959859},{"date":"2026-04-10","current":-29.593377,"twenty":-20.420045,"median":-4.385799,"eighty":-2.920519,"marketCap":14827089388},{"date":"2026-04-17","current":-29.673335,"twenty":-20.493961,"median":-4.385799,"eighty":-2.920519,"marketCap":14873393340},{"date":"2026-04-24","current":-30.832617,"twenty":-20.822018,"median":-4.385799,"eighty":-2.920519,"marketCap":15455344849},{"date":"2026-04-30","current":-29.603766,"twenty":-21.040655,"median":-4.385799,"eighty":-2.920519,"marketCap":14848626766},{"date":"2026-05-08","current":-26.809523,"twenty":-21.31078,"median":-4.359302,"eighty":-2.920458,"marketCap":13488807400},{"date":"2026-05-15","current":-25.630341,"twenty":-21.467249,"median":-4.359302,"eighty":-2.920458,"marketCap":12929437425},{"date":"2026-05-22","current":-25.466772,"twenty":-21.685779,"median":-4.385799,"eighty":-2.920519,"marketCap":12817563430},{"date":"2026-05-29","current":-25.473606,"twenty":-21.884806,"median":-4.359302,"eighty":-2.920458,"marketCap":12865585130},{"date":"2026-06-05","current":-14.851235,"twenty":-21.884806,"median":-4.359302,"eighty":-2.920458,"marketCap":7511583865},{"date":"2026-06-12","current":-14.766427,"twenty":-21.884806,"median":-4.359302,"eighty":-2.920458,"marketCap":7463637585},{"date":"2026-06-18","current":-14.604908,"twenty":-21.880534,"median":-4.385799,"eighty":-2.920519,"marketCap":7399709211},{"date":"2026-06-26","current":-13.979206,"twenty":-21.884806,"median":-4.359302,"eighty":-2.920458,"marketCap":7048103158},{"date":"2026-07-03","current":-17.167949,"twenty":-21.884806,"median":-4.359302,"eighty":-2.920458,"marketCap":8662294584},{"date":"2026-07-10","current":-16.745047,"twenty":-21.884806,"median":-4.359302,"eighty":-2.920458,"marketCap":8438545278},{"date":"2026-07-17","current":-14.315543,"twenty":-21.884806,"median":-4.359302,"eighty":-2.920458,"marketCap":7239888278},{"date":"2026-07-24","current":-14.596678,"twenty":-21.884806,"median":-4.359302,"eighty":-2.920458,"marketCap":7383727118},{"date":"2026-07-31","current":-13.622962,"twenty":-21.889079,"median":-4.358449,"eighty":-2.920396,"marketCap":6904264318},{"date":"2026-08-07","current":-16.539337,"twenty":-21.889079,"median":-4.358449,"eighty":-2.920396,"marketCap":8398590044},{"date":"2026-08-14","current":-18.058677,"twenty":-21.889079,"median":-4.358449,"eighty":-2.920396,"marketCap":9181712618},{"date":"2026-08-21","current":-16.885224,"twenty":-21.889079,"median":-4.358449,"eighty":-2.920396,"marketCap":8604057841},{"date":"2026-08-28","current":-19.208873,"twenty":-21.889079,"median":-4.358449,"eighty":-2.920396,"marketCap":9389321617},{"date":"2026-09-04","current":-20.179153,"twenty":-21.889079,"median":-4.358449,"eighty":-2.920396,"marketCap":9867555316},{"date":"2026-09-10","current":-19.793845,"twenty":-21.889079,"median":-4.358449,"eighty":-2.920396,"marketCap":9692202960}],"updateTime":1789130495498},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02616\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2626127550","title":"Evaluating CStone Pharmaceuticals (SEHK:2616) After ESMO Category I A Backing For Sugemalimab","url":"https://stock-news.laohu8.com/highlight/detail?id=2626127550","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626127550?lang=en_us&edition=fundamental","pubTime":"2026-04-12 01:18","pubTimestamp":1775927912,"startTime":"0","endTime":"0","summary":"Sugemalimab’s new Category I, A recommendation in European Society for Medical Oncology guidance for early and locally advanced non small cell lung cancer puts CStone Pharmaceuticals (SEHK:2616) firmly in focus for investors tracking oncology developments.\nSee our latest analysis for CStone Pharmaceuticals.\nThe ESMO endorsement arrives alongside strong recent trading, with the HK$10.07 share price supported by a 30 day share price return of 38.32% and a 1 year total shareholder return above...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2616/cstone-pharmaceuticals-shares/news/evaluating-cstone-pharmaceuticals-sehk2616-after-esmo-catego","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2616/cstone-pharmaceuticals-shares/news/evaluating-cstone-pharmaceuticals-sehk2616-after-esmo-catego","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","02616","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198400412","title":"Stock Track | CSTONE PHARMA-B Soars 6.73% Intraday on Positive CS2009 Trial Data and Analyst Upgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=1198400412","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198400412?lang=en_us&edition=fundamental","pubTime":"2026-04-10 13:59","pubTimestamp":1775800745,"startTime":"0","endTime":"0","summary":"CSTONE PHARMA-B's stock surged 6.73% during intraday trading, reflecting strong investor optimism following recent positive clinical updates and a significant analyst action.The movement is primarily...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191475771","title":"CSTONE PHARMA-B Shares Surge Over 6% in Afternoon Trading on Analyst Upgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=1191475771","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191475771?lang=en_us&edition=fundamental","pubTime":"2026-04-10 13:56","pubTimestamp":1775800578,"startTime":"0","endTime":"0","summary":"CSTONE PHARMA-B (02616) rose more than 6% in afternoon trading. At the time of writing, the stock was up 6.73%, trading at HK$10.15 with a turnover of HK$120 million. The movement follows recent news...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","BK4588","02616","VXUS","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162189108","title":"CStone Pharma Reports Marginal Share Capital Movement in March; Issues 3,349 New Shares via Option Exercise","url":"https://stock-news.laohu8.com/highlight/detail?id=1162189108","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162189108?lang=en_us&edition=fundamental","pubTime":"2026-04-09 19:04","pubTimestamp":1775732661,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals (CStone Pharma) filed its Monthly Return for the period ended 31 March 2026, detailing only minor changes to its share capital structure. The company’s authorised share capital...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141046749","title":"CStone Pharmaceuticals shifts to fully electronic distribution of corporate communications effective 2 April 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1141046749","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141046749?lang=en_us&edition=fundamental","pubTime":"2026-04-02 17:25","pubTimestamp":1775121914,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals announced that, in line with Rule 2.07 of the Hong Kong Stock Exchange’s expanded paperless listing regime effective 31 December 2023, all future corporate communications will...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624416715","title":"Adlai Nortye names Archie Tse president as Kaiyang Tang retires","url":"https://stock-news.laohu8.com/highlight/detail?id=2624416715","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624416715?lang=en_us&edition=fundamental","pubTime":"2026-04-02 04:34","pubTimestamp":1775075658,"startTime":"0","endTime":"0","summary":"Adlai Nortye appointed Archie Tse as president effective April 1, 2026, while he continues as head of research and development.Tse has led R&D since March 2024; he previously served at CStone Pharmaceuticals, including as chief scientific officer and senior vice president.Ye has served as interim CFO since January 2025; he previously held business development roles at inVentiv Health  and leadership posts at GenScript and Patheon.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adlai Nortye Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 01, 2026, and is solely responsible for t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL4MFJVL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z8X17.USD","LU0345770993.USD","IE0034235188.USD","LU2211814178.USD","IE00B2B36J28.USD","LU2211815571.USD","LU1291159041.SGD","LU1923621640.USD","BK4534","BK4581","LU1670628061.USD","LU0096362180.USD","LU1633808545.USD","LU0114720955.EUR","LU1854103824.USD","LU1803068623.USD","LU2360108059.USD","LU1923622614.USD","LU2125909759.SGD","IE0009355771.USD","LU0070302665.USD","LU2125909916.SGD","LU2764262908.HKD","LU2543165471.USD","LU0266013472.USD","LU0823416689.USD","LU1923622291.USD","LU1988902786.USD","IE00B1BXHZ80.USD","IE00B4R5TH58.HKD","LU1791710582.SGD","02616","IE00B19Z8W00.USD","IE00BFTCPJ56.SGD","LU0528227936.USD","ANL","TMO","BK4588","LU0557290698.USD","IE00BKPKM429.USD","LU1983299246.USD","BK4533","LU2125909247.SGD","LU1670627923.USD","IE0002141913.USD","LU1791710400.SGD","LU2063271972.USD","LU0957791311.USD","BK4566","LU0345770308.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624455931","title":"Gushengtang appoints Boyu Capital partner Cao Yanling as non-executive director","url":"https://stock-news.laohu8.com/highlight/detail?id=2624455931","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624455931?lang=en_us&edition=fundamental","pubTime":"2026-04-01 06:28","pubTimestamp":1774996132,"startTime":"0","endTime":"0","summary":"Gushengtang appointed Cao Yanling as non-executive director effective March 31, 2026.Cao is a founder-partner at Boyu Capital, focusing on healthcare investments.He previously worked at General Atlantic as senior investment manager, preceded by investment banking role at Goldman Sachs Asia.Cao has held board roles across healthcare companies, including WuXi Biologics, Ocumension Therapeutics, CStone Pharmaceuticals.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gushengtang Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 31, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL7k6jBJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","LU1868837136.USD","LU2039709279.SGD","IE00B19Z3581.USD","BK4504","BK4588","LU0516423091.SGD","BK1589","IE00BFXG1179.USD","LU0856984785.SGD","LU2750360641.GBP","LU0251142724.SGD","02273","LU0819121731.USD","02269","LU2237443895.HKD","LU2471134879.HKD","LU1242518857.USD","LU3063872942.SGD","IE0002270589.USD","02616","LU0823426480.USD","LU2237443549.SGD","LU0456827905.SGD","LU2237443382.USD","01477","GSX","LU0251131958.USD","LU2237438978.USD","LU0051755006.USD","LU0417516738.SGD","BK1191","BK1521","IE0004086264.USD","LU0708995583.HKD","LU0979878070.USD","BK4516","BK4533","LU1242518931.SGD","LU2471134796.USD","LU0181495838.USD","LU0742534661.SGD","LU2237443622.USD","LU0348735423.USD","BK4127","LU0572944931.SGD","LU0106831901.USD","LU1804176565.USD","LU1794554557.SGD","LU1868836914.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623377669","title":"A Look At CStone Pharmaceuticals (SEHK:2616) Valuation After Encouraging CS2009 Trial Results And Wider Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2623377669","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623377669?lang=en_us&edition=fundamental","pubTime":"2026-03-31 10:07","pubTimestamp":1774922859,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals (SEHK:2616) has drawn fresh attention after reporting detailed Phase I/II data for CS2009, its trispecific antibody, alongside full year 2025 results that show CNY 269.58 million in sales and a CNY 437 million net loss.\nSee our latest analysis for CStone Pharmaceuticals.\nThe encouraging CS2009 data appears to be feeding into a strong shift in sentiment, with a 1 day share price return of 5.04% and a 7 day share price return of 40.68% at HK$8.75. Momentum has been...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2616/cstone-pharmaceuticals-shares/news/a-look-at-cstone-pharmaceuticals-sehk2616-valuation-after-en","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2616/cstone-pharmaceuticals-shares/news/a-look-at-cstone-pharmaceuticals-sehk2616-valuation-after-en","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","BK1161","BK1574","02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190381168","title":"Stock Track | CStone Pharma-B Soars 5.04% Intraday on Bullish Analyst Reports and Positive CS2009 Clinical Data","url":"https://stock-news.laohu8.com/highlight/detail?id=1190381168","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190381168?lang=en_us&edition=fundamental","pubTime":"2026-03-30 13:36","pubTimestamp":1774848996,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals' stock surged 5.04% during the intraday session, following the release of highly positive research reports from two major international investment banks.Jefferies maintained...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173745104","title":"Two Major Foreign Institutions Bullish on CStone Pharma: Peak Target Price Set at HK$20, CS2009 Emerges as Key Catalyst","url":"https://stock-news.laohu8.com/highlight/detail?id=1173745104","media":"Stock News","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173745104?lang=en_us&edition=fundamental","pubTime":"2026-03-30 09:26","pubTimestamp":1774833998,"startTime":"0","endTime":"0","summary":"Recent research reports from multiple international investment firms have expressed positive views on the clinical data and commercial prospects of CStone Pharmaceuticals' core investigational...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622181426","title":"CStone Pharmaceuticals' Loss Widens in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2622181426","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622181426?lang=en_us&edition=fundamental","pubTime":"2026-03-27 12:30","pubTimestamp":1774585858,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals  booked a loss of 437 million yuan in 2025, widening from 91.2 million yuan a year earlier, according to a Thursday Hong Kong bourse filing.Shares of the pharmaceutical firm were up nearly 18% in late Friday morning trade.Loss per share came in at 0.31 yuan, compared with 0.07 yuan a year earlier.Revenue fell 34% to 269.6 million yuan from 407.2 million yuan.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1574","02616","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135867297","title":"CStone Pharmaceuticals-B Surges Over 20% by Late Morning on Strong CS2009 Lung Cancer Efficacy Data","url":"https://stock-news.laohu8.com/highlight/detail?id=1135867297","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135867297?lang=en_us&edition=fundamental","pubTime":"2026-03-27 11:50","pubTimestamp":1774583426,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals-B (02616) saw its gains expand to over 20% by late morning. At the time of writing, the stock was up 20.29%, trading at HK$8.30, with a turnover of HK$390 million. The company...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02616","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184614767","title":"CSTONE PHARMA-B (02616) Surges Over 20% on Strong CS2009 Lung Cancer Efficacy Data; First Phase III Global Trials Expected This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1184614767","media":"Stock News","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184614767?lang=en_us&edition=fundamental","pubTime":"2026-03-27 11:32","pubTimestamp":1774582341,"startTime":"0","endTime":"0","summary":"CSTONE PHARMA-B (02616) saw its gains expand beyond 20%. At the time of writing, the stock was up 19.42% to HK$8.24, with a turnover of HK$377 million. The surge follows the company's announcement of...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","02616","BK1574","III","BK4585","BK4134","BK1161","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134940401","title":"Stock Track | CStone Pharma Soars 5.51% Intraday on Strong 2025 Results and Promising Pipeline Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=1134940401","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134940401?lang=en_us&edition=fundamental","pubTime":"2026-03-27 09:39","pubTimestamp":1774575550,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals' stock surged 5.51% during intraday trading on Friday, following the release of its 2025 annual results which highlighted significant strategic and clinical advancements.The...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622247863","title":"Press Release: CStone Announces 2025 Annual Results: Accelerated Expansion of Global Commercial Footprint and Efficient Advancement of Innovation Pipeline 2.0","url":"https://stock-news.laohu8.com/highlight/detail?id=2622247863","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622247863?lang=en_us&edition=fundamental","pubTime":"2026-03-26 21:32","pubTimestamp":1774531920,"startTime":"0","endTime":"0","summary":"-- The global, multicenter Phase I/II clinical trial of CS2009. Australia and China, and the Phase II IND application has been approved. in the US. CS2009 demonstrates an excellent safety profile with a >=Grade. 3 TRAE rate of 23%, along with broad-spectrum anti-tumor activity.Notably, monotherapy data in lung cancer are encouraging: in first-line. NSCLC patients with PD-L1 TPS >=50%, the ORR reached 90% with a DCR of. 100%, while the ORR was 25% in IO-pretreated NSCLC .Furthermore, significant benefits were observed in patients with heavily. pre-treated \"cold tumors,\" achieving an ORR of 40% in non-clear cell. renal cell carcinoma  and 33.3% in soft tissue sarcoma .-- The global Phase Ib multicenter trial of CS5001  is being. advanced rapidly and efficiently in Australia and China, with its R&D. progress ranking among the top two globally. In combination with R-CHOP. rate exceeds 90%, and the ORR reaches 100%. Additionally, the combination. complementing its successful NRDL renewal at","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","IE00BFXG0V08.USD","LU0456854461.SGD","BK4022","BK4213","BK4567","ORR","L","LU1169590202.USD","BK4548","LU2413666699.HKD","BK4588","BK4006","BK4533","PK","BK4156","LU0347712357.USD","LU1169589451.USD","BK4232","PD","BK4023","IE00BYQQ9H92.USD","LU0266512127.USD","BK4181","LU0210528500.USD","02616","BK1574","CRC","BK4218","LU2211817866.USD","IE00B5TLWC47.USD","BK4107","LU1093756325.SGD","LU2487616109.SGD","HCC","CC","BK4585","LU1721428933.USD","LU2413666426.HKD","LU0053666078.USD","PROC","R","LU1093756168.USD","BK4007","BK4098","BK1161","MTD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622850657","title":"CStone Pharmaceuticals -  Loss for the Year Was RMB437.0 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622850657","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622850657?lang=en_us&edition=fundamental","pubTime":"2026-03-26 20:43","pubTimestamp":1774529020,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E0JB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02616","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622850658","title":"CStone Pharmaceuticals FY2025; revenue drops 33.8% to RMB 270 million due to lower licensing fees","url":"https://stock-news.laohu8.com/highlight/detail?id=2622850658","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622850658?lang=en_us&edition=fundamental","pubTime":"2026-03-26 20:43","pubTimestamp":1774529009,"startTime":"0","endTime":"0","summary":"CStone reported expanded international regulatory approvals for sugemalimab in the EU and the UK, adding an additional indication in III-stage NSCLC.The company also signed commercialization agreements for sugemalimab covering 10 Latin American countries and 23 Western European countries plus the UK.CStone said it has established partnerships that extend sugemalimab’s international reach to more than 60 countries.In China, pralsetinib was added to the national reimbursement drug list effective January 1, 2026, which the company expects to support future demand.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CStone Pharmaceuticals published the original content used to generate this news brief via IIS, the Issuer Information Service ope","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL24Pm23:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02616","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104410716","title":"CStone reports 90% ORR in first-line NSCLC for trispecific antibody CS2009; Phase III global trials slated for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1104410716","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104410716?lang=en_us&edition=fundamental","pubTime":"2026-03-26 17:23","pubTimestamp":1774517028,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals (CStone) released a voluntary update on the clinical progress of its self-developed trispecific antibody CS2009 (PD-1/VEGF/CTLA-4), highlighting an improved safety profile,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189079157","title":"CStone Pharmaceuticals-B Unveils Latest Clinical Progress and Phase I/II Key Data for Trispecific Antibody CS2009","url":"https://stock-news.laohu8.com/highlight/detail?id=1189079157","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189079157?lang=en_us&edition=fundamental","pubTime":"2026-03-26 17:21","pubTimestamp":1774516865,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals-B (02616) has announced the latest clinical progress for its internally developed PD-1/VEGF/CTLA-4 trispecific antibody, CS2009. The data demonstrate an excellent safety...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK4023","BK1161","LU1169589451.USD","PD","02616","LU1169590202.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622307678","title":"CStone Pharmaceuticals reports CS2009 Phase I safety; Grade ≥3 TRAEs rise to 23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622307678","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622307678?lang=en_us&edition=fundamental","pubTime":"2026-03-26 17:01","pubTimestamp":1774515690,"startTime":"0","endTime":"0","summary":"CStone reported updated Phase I/II clinical progress for CS2009, a PD-1/VEGF/CTLA-4 trispecific antibody, from ongoing trials in Australia and China.As of mid-March 2026, Phase I enrolled 113 patients with advanced solid tumors and reported a 23% incidence of Grade ≥3 treatment-related adverse events.In Phase II first-line NSCLC with PD-L1 TPS ≥50%, CS2009 monotherapy showed a 90% overall response rate and a 100% disease control rate.The company said updated Phase I and Phase II data are expected to be presented at the 2026 ASCO Annual Meeting and/or the 2026 ESMO Congress.CStone plans to initiate Phase III global multi-regional clinical trials for CS2009 by the end of 2026 in indications including NSCLC and colorectal cancer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL70Wbzt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02616","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":7,"totalSize":148,"code":"91000000","status":"200"}]}}